Cargando…
Can India lead the way in neglected diseases innovation?
Nirmal Kumar Ganguly and colleagues call for a comprehensive policy for neglected diseases research in India to foster innovation in drugs, diagnostics, and vaccines, critical for evolving needs of elimination programmes
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group Ltd.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340354/ https://www.ncbi.nlm.nih.gov/pubmed/30670384 http://dx.doi.org/10.1136/bmj.k5396 |
| _version_ | 1783388779959025664 |
|---|---|
| author | Thomas, Zakir Saha, Gautam Kumar Gopakumar, Kappoori Madhavan Ganguly, Nirmal Kumar |
| author_facet | Thomas, Zakir Saha, Gautam Kumar Gopakumar, Kappoori Madhavan Ganguly, Nirmal Kumar |
| author_sort | Thomas, Zakir |
| collection | PubMed |
| description | Nirmal Kumar Ganguly and colleagues call for a comprehensive policy for neglected diseases research in India to foster innovation in drugs, diagnostics, and vaccines, critical for evolving needs of elimination programmes |
| format | Online Article Text |
| id | pubmed-6340354 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BMJ Publishing Group Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63403542019-02-02 Can India lead the way in neglected diseases innovation? Thomas, Zakir Saha, Gautam Kumar Gopakumar, Kappoori Madhavan Ganguly, Nirmal Kumar BMJ Analysis Nirmal Kumar Ganguly and colleagues call for a comprehensive policy for neglected diseases research in India to foster innovation in drugs, diagnostics, and vaccines, critical for evolving needs of elimination programmes BMJ Publishing Group Ltd. 2019-01-22 /pmc/articles/PMC6340354/ /pubmed/30670384 http://dx.doi.org/10.1136/bmj.k5396 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Analysis Thomas, Zakir Saha, Gautam Kumar Gopakumar, Kappoori Madhavan Ganguly, Nirmal Kumar Can India lead the way in neglected diseases innovation? |
| title | Can India lead the way in neglected diseases innovation? |
| title_full | Can India lead the way in neglected diseases innovation? |
| title_fullStr | Can India lead the way in neglected diseases innovation? |
| title_full_unstemmed | Can India lead the way in neglected diseases innovation? |
| title_short | Can India lead the way in neglected diseases innovation? |
| title_sort | can india lead the way in neglected diseases innovation? |
| topic | Analysis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340354/ https://www.ncbi.nlm.nih.gov/pubmed/30670384 http://dx.doi.org/10.1136/bmj.k5396 |
| work_keys_str_mv | AT thomaszakir canindialeadthewayinneglecteddiseasesinnovation AT sahagautamkumar canindialeadthewayinneglecteddiseasesinnovation AT gopakumarkappoorimadhavan canindialeadthewayinneglecteddiseasesinnovation AT gangulynirmalkumar canindialeadthewayinneglecteddiseasesinnovation |